search_icon 

close_icon

search_icon  

search_icon  

 

Curriculum vitae

 

Ao. Univ. Prof. Mag. Dr. Florian Überall, PhD, Retired

 

Nationality: Austrian

Date of Birth: 30th April, 1954

Birthplace: Kitzbühel, Tyrol

CCB Florian Überall

 

Contact:

Center of Chemistry and Biomedicine Innsbruck
Division of Medical Biochemistry
Eco- & Nutritional Biochemistry & Nutrigenomics

Innsbruck Medical University
Innrain 80-82
6020 Innsbruck
Austria

 

PHONE: +43-512-9003-70120

FAX: ++43-512-9003-73130

email: florian.ueberall@i-med.ac.at

 

 

Educational Details

1982-1986     

Undergraduate Studies in Biology, University of Innsbruck

1986-1988 Diploma Thesis in Microbiology – Mag. rer. nat., University of Innsbruck

1986-1988

Master Thesis in Medical Chemistry and Biochemistry – MSc., Faculty of Medicine, University of Innsbruck

 

PhD Thesis in Biochemistry, Role of protein kinase C isotypes in mitogenic cell signalling, Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, University of Innsbruck

1992   PhD in Microbiology and Biochemistry

 

Professional Career

1993 Assistant Professor, Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, University of Innsbruck

Since 1999  Group Leader - Signal Transduction Group

2001 Group Leader, Marie Curie Training Site, Eurogendis Program on the Genetic Basis of Diseases, EU

2000    Associate Professor for Medical Biochemistry

Since 2002 Lecturer, Postgraduate Studies in Molecular Biology (MCB), Faculty of Medicine, University of Innsbruck

 

Lecturer, Special Biochemical Aspects of Nutrition & Nutrigenomics

Since 2013

Lecturer, Volatilome - Signal transduction of volatile organic compounds

Lecturer, Nutritional Sciences - Shaping Trends for 2030

 

Scientific Projects & Career-related Activities

1993-2003  Project leader, SFB-Research Grant F208, Mitogenic signal transduction cascades, Role of protein kinase C and integrin-mediated signals in mitogenic signal transduction, University of Innsbruck

1996-1999 Project leader, Research Grant, Synthetic and microbial inhibitors of signal-transducing enzymes for cancer treatment, BMBF-ASTA Medica, Frankfurt, Germany

1997-2001 Project leader, Research Grant, Atypical PKC-lambda and iota: New targets for anti-proliferative interactions and modern chemotherapy,

Altana Pharma (Byk-Gulden), Konstanz, Germany

1999-2001 General Secretary, Austrian Society of Biochemistry and Molecular Biology

(OGBM)

2002-2004 Project leader, Research Grant, Atypical PKC isotypes: Novel targets of tumour therapy, Schering AG, Berlin, Germany

2001-2003 Project leader, Research Grant, mTOR signalling, ROCHE-Penzberg, Germany

2002-2003   Project leader, Research Grant, PADMA28, PADMAQ and SarsaQ: Expression profiling and gene analysis, PADMA AG, Schwerzenbach, Switzerland

2001-2008 FEBS Delegate, Austrian Society of Biochemistry and Molecular Biology (OGBM)

Since 2003 

Project leader, SFB Research Grant 021,

Cell Proliferation and Cell Death in Tumors, Molecular Mechanisms Underlying the Interplay of Proliferation and Apoptosis, Medical University of Innsbruck

2004 Group leader Medical University, Functional Gene Expression Bioinformatics Unit

(FGBU)

2004-2006 General Project leader, FFG-Basic program (FFG 809969) Ultrahomogene Liquidverkapselung von Naturstoffen – Ultrahomogene Liquidencapsulation of natural compounds

2005-2012  Advisory Board Member, TAM Beiratsmitglied, Bundesministerium für Gesundheit (Minister Rauch-Kallert, Kdolsky, Stöger) Traditional Asian Medicine Systems

2006-2008 General Project leader, FFG-Fabrik der Zukunft (FFG 812912), Recovery and molecular testing of biomolecules resulting from process gas condensation of thermic wood processing
2007-2009 General Project leader, FFG-Fabrik der Zukunft (FFG 816594)

Biological Wood Protection Products

2009-2010  General Project leader, FFG-Fabrik der Zukunft (FFG 828281)Biological Wood Protection Products
2007-2011  General Project leader, Responder-Non-Responder Classification, Dermatologische

Spezialklinik Neukirchen, Germany

2008-2011

General Project leader, (FFG 818111), PHYTEST(Bridge),

Establishment of in-vitro models for a risk-benefit assessment of phytochemicals

2012-2015 

General Project leader, VOCONCELL (FFG 834169, Bridge Call),

Cellular and molecular risk  assessment of volatile organic compounds from wood-based materials on human cell models using a new type of emission and exposure chamber

2012-2013 General Project leader, PHYTORAF (FFG 834251, Bridge Call), Analysis of bioactive       extracts – cascading use of waste from plant harvest and processing

 

2012-2014

Co-Applicant, (FWF-P24168-B16, Univ. Doz. Dr. Markus Ganzera),

Abiotic stress in extremophiles – strategies and utilization

2012-2015  Advisory Board Member, TAM Beiratsmitglied, Bundesministerium für Gesundheit (Minister Rauch-Kallert, Kdolsky, Stöger), Traditional Asian Medicine Systems

2013-2015

General project leader, Nutritional Science - Shaping Trends for 2030, Philips Consumer Lifestyle, Klagenfurt, Austria

 

2014-2016

Co-Applicant, FEMtech, Development of a personalized responder-non-responder CYP2D6 breathing gas classification assay

 

 Awards

1989 

1st Austrian Award for Chemotherapy, Lilly-Prize, Vienna

1998

Together with Sonja Kampfer, Aventis Prize

2000

Together with Karina Hellbert, Aventis Prize

2000   

Together with Franz Hochholdinger, Prize of the City of Innsbruck

 

Memberships

  • Austrian Society of Biochemistry and Molecular Biology (OGBM)
  • Austrian Society of Genetic and Gene-Technology (OGGGT) Austrian Cancer Society (ACS)
  • American Association for Cancer Research (AACR)
  • Austrian Society for Phytotherapy (ÖGPhyt)
  • Austrian Association of Molecular Life Sciences and Biotechnology (ÖGMBT)
  • Advisory Board Member, TAM, Austrian Federal Ministry of Health

 

Scientific Advisor

  • Co-Editor, Synergy, Elsevier 2013
  • Editorial Board Journal of Phytomedicine – International Journal of Phytotherapy and Phytopharmacology
  • Austrian Department of Health and Human Services (Ministry of Health)
  • General Secretary, Austrian Society of Biochemistry and Molecular Biology
  • EMBO Journal, FEBS Letters, J. Biol. Chemistry, Schweiz. Z. Ganzheitsmedizin

 

International Collaborators

  • Altieri D, Department of Pathology, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut, USA. Role of PKC isotypes in survivin expression;
  • Biden T, Garvan Institute, Metabolic Diseases, Sydney Australia, Atypical PKC-iota in insulin signaling;
  • Pestell R, Cornell University, New York, USA, Cyclin D1 signal transmission. Role of PKC isotypes;
  • Ullrich A, MPI for Biochemistry, Martinsried, Germany, Signaling of Trk- and EGF receptor mutants;
  • Ulrich-Merzenich G, Medizinische Poliklinik/Medizinische Klinik III, Bonn, Nutrigenomics, VOC signaling;
  • Moscat Jorge, Sanford Burchham, La Jolla, USA, Role of atypical PKC in apoptosis and survival;
  • Jörn Probst & Karin Bockelmann, Fraunhofer Insitute ISC, Würzburg, Germany, Biologicl functions of N-chlorotaurin;

  

Research interests

Nutrigenomic analysis - Systemic interactome - Nutrients => Genes => Health

Gene expression profiling, genome-wide network fingerprinting

Cellular analysis of volatile organic compounds - risk-benefit assessment

Signal transduction of natural compounds

Regulation of redox-sensitive genes

Ecological chemistry

Cancer signalling 

 

Lectures

262 invited lectures were held (in Austria & international e.g. in the USA, Germany, Switzerland, Italy, Spain and Turkey)

 

Selected publications (last five years)

 

  • Becker K, Becker K, Fuchs D, Gostner J, Überall F. Immunomodulatory properties of cacao extracts – potential consequences of medical application. Frontiers in Pharmacology 2013, doi: 10.3389/fphar.2013.00154

 

  • Becker K, Schroecksnadel S, Gostner J, Zaknun C, Schennach H, Ueberall F, Fuchs D. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine. 2013 Sep 13. pii: S0944-7113(13)00311-5. doi: 10.1016/j.phymed.2013.08.008

 

  • Huemer HP, Geiger M, Posch W, Krumböck N, Fresser F, Wilflingseder D, Ueberall F. Protein kinase C overexpression does not enhance immune-stimulatory surface markers of vaccinia-infected dendritic cells and DC cell lines. Immunol Invest. 2013;42(2):164-77. doi: 10.3109/08820139.2012.750340.

 

  • Klein A, Wrulich OA, Jenny M, Gruber P, Becker K, Fuchs D, Gostner J, Überall F. Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies. BMC Genomics 2013, 14:133

 

  • Gostner JM, Schröcksnadel S, Becker K, Jenny M, Schennach H, Uberall F, Fuchs D. Antimalaria drug chloroquine counteracts activation of indolamine (2,3)-dioxygenase activity in human PBMC. FEBS Open Bio. 2012 Aug 17;2:241-5

 

  • Crespo JA, Stöckl P, Ueberall F, Jenny M, Saria A, Zernig G. Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary fort he retrieval, consolidation and reconsolidation of drug memeory, PLoS One 2012, 7: e30502.

  • Gostner J, Wrulich OA, Jenny M, Fuchs D, Ueberall F. An update on the strategies in multicomponent activity monitoring within the phytopharmacaeutical field. BMC Complement Altern Med., 2012, 14:12-18.

  • Crespo JA, Stöckl P, Ueberall F, Jenny M, Saria A, Zernig G. Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary for the retrieval, consolidation and reconsolidation of drug memeory, PLoS One 2012, 7: e30502.

  • Jenny M, Wondrak A, Zvetkova E, Ngoc Tram NT, Phi TP, Schennach H, Culig Z, Ueberall F, Fuchs D, Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells, Epub. (2011).

  • Jenny M, Schroecksnadel S, Ueberall F, Fuchs D. The potential role of cannabinoids in modulating serotonergic signalling by their influence on tryptophan metabolism, Pharmaceuticals, 2010, 3: 2647-2660.

  • Ciardi C, Jenny M, Tschoner A, Ueberall F, Patsch J, Pedrini M, Ebenbichler C, Fuchs D. Food additives sodium sulfite, sodium benzoate and curcumin inhibit leptin release in murine adipocytes in vitro, Epub, (2011).

  • Morandell S, Grosstessner-Hain K, Roitinger E, Lindhorst T, Teis D, Wrulich AO, Mazanek M, Taus T, Ueberall F, Mechtler K, Huber LA. QIKS - Quantitative identification of kinase substrates. Proteomics, 2010, 10: 2015-2025.

  • Maier E, Kurz K, Jenny M, Schennach H, Ueberall F, Fuchs D. Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro. Food Chem Toxicol., 2010, 48(7): 1950-1956.

  • Narazenko I, Jenny M, Keil J, Gieseler C, Weisshaupt K, Sehouli J, Legewie S, Herbst L, Weichert W, Darb-Esfahani S, Dietel M, Schäfer R, Ueberall F, Sers C. Atypical Protein Kinase C z Exhibits a Proapoptotic Function in Ovarian Cancer. Mol Cancer Res., 2010, 8(6): 919-34.

  • Schroecksnadel S, Jenny M, Kurz K, Klein A, Ledochowski M, Uberall F, Fuchs D. LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun., 2010, 399: 642-646.

  • Jenny M, Santer E, Klein A, Ledochowski M, Schennach H, Ueberall F, Fuchs D, Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells. Journal of Ethnopharmacology, 2009, 122:261-267.

  • Malinowska K, Cavarretta IT, Susani M, Wrulich OA, Ueberall F, Kenner L, Culig Z. Identification of µ- crystallin as an androgen-regulated gene in human prostate cancer. The Prostate, 2009, 69: 1109-1118.

  • Irschick EU, Haas G, Troger J, Ueberall F, Huemer HP. Involvement of protein kinase C in phagocytosis of human retinal pigment epithelial cells and induction of matrix metalloproteinase secretion. Int Ophthalmol., 2009, 5: 333-41.

  • Gruber T, Fresser F, Jenny M, Ueberall F, Leitges M, Baier G. PKCtheta cooperates with atypical PKCzeta and PKCiota in NF-kappaB transactivation of T lymphocytes. Mol Immunol., 2007, 45(1): 117-126.

 

 

12 selected publications of the entire working period

  • Klein A, Wrulich OA, Jenny M, Gruber P, Becker K, Fuchs D, Gostner J, Überall F. Pathway-fossued bioassays and transcriptome abnalysis contribute to a better activity monitoring of complex herbal remedies. BMC Genomics 2013, 14:133

 

  • Crespo JA, Stöckl P, Ueberall F, Jenny M, Saria A, Zernig G. Activation of PKCzeta and PKMzeta in the nucleus accumbens core is necessary for the retrieval, consolidation and reconsolidation of drug memeory, PLoS One 2012, 7: e30502.

 

  • Gostner J, Wrulich OA, Jenny M, Fuchs D, Ueberall F. An update on the strategies in multicomponent activity monitoring within the phytopharmaceutical field. BMC Complement Altern Med, 2012, 14:12-18.

 

  • Morandell S, Grosstessner-Hain K, Roitinger E, Lindhorst T, Teis D, Wrulich AO, Mazanek M, Taus T, Ueberall F, Mechtler K, Huber LA. QIKS - Quantitative identification of kinase substrates. Proteomics, 2010, 10: 2015-2025.

 

  • Gruber T, Fresser F, Jenny M, Ueberall F, Leitges M, Baier G. PKCtheta cooperates with atypical PKCzeta and PKCiota in NF-kappaB transactivation of T lymphocytes. Mol Immunol., 2007, 45(1): 117-126.

 

  • Sonja Kampfer, Michaela Windegger, Wolfgang Schwaiger, Richard G. Pestell, Gottfried Baier, Hans H. Grunicke, and Florian Überall. Protein kinase C isoforms involved in the transcriptional activation of Cyclin D1 by transforming Ha-Ras. J. Biol. Chem., 2001, 276: 42834-42842.

 

  • Mwanjewe J, Spitaler, M, Kampfer S, Hofmann J, Florian Überall, and Grunicke H. Regulation of phospholipase D (PLD) isoenzymes by transforming Ras and atypical aPKC-iota. Biochem. J., 2001, 359: 211-217.

 

  • Martin Spitaler, Andreas Villunger, Hans H. Grunicke and Überall F. Unique structural and functional properties of the ATP binding domain of atypical Protein kinas C-iota. J. Biol. Chem., 2000, 275: 33289-33296.

 

  • Sonja Kampfer, Karina Hellbert, Andreas Villunger, Wolfgang Doppler, Gottfried Baier, G., Hans H. Grunicke, and Florian Überall. Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-iota, epsilon and zeta. EMBO J., 1998, 17: 4046-4055.

 

  • Florian Überall, Karina Hellbert, Sonja Kampfer, Karl Maly, Andreas Villunger, Martin Spitaler, James Mwanjewe, Gottfried Baier, and Hans H., Grunicke. Evidence for an implication of atypical protein kinase C-lambda and in Ras-mediated reorganization of the F-actin cytoskeleton. J. Cell. Biol., 1999, 24: 23-34.

 

  • Florian Überall, Karina Hellbert, Sonja Kampfer, Karl Maly, Andreas Villunger, Martin Spitaler, James Mwanjewe, Gottfried Baier, and Hans H. Grunicke. Induced reorganization of actin cytoskeleton is mediated by protein kinase C isoforms lambda and zeta. Nature Biotechnology Short Reports, 1999, 10: 51.

 

  • Franz Hochholdinger, Gottfried Baier, Anto Nogalo, Birgitt Bauer, Hans H., Grunicke, and Florian Überall. Novel membrane-targeted ERK-1 and ERK-2 mutants which act as dominant negative, isotype-specific MAP kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH3T3 cells. Mol. Cell. Biol., 1999, 19: 8052-8065.

 

 

Books

  • Wrulich OW, Überall F, Nutrigenomik: Regulation der Genexpression durch Nährstoffe, Klinische Ernährungsmedizin, Ledochowski M, 2009, (Hrsg.), Springer Verlag, ISBN: 978-3-211-88899-5

 

  • Überall A, Überall F: Herb- und Bitterstoffe, AT-Verlag Aarau, ISBN 978-3-03800-755-5

 

 

Reviews

  • Becker K, Becker K, Fuchs D, Gostner J, Überall F. Immunomodulatory properties of cacao extracts – potential consequences of medical application. Frontiers in Pharmacology 2013, doi: 10.3389/fphar.2013.00154.

 

  • Gostner JM, Gruber P, Becker K, Naschberger M, Uberall F. New approaches to elucidate the activities of botanical multi-component mixtures. Forsch Komplementmed. 2013;20 Suppl 2:41-4. doi: 10.1159/000351739. Epub 2013 Jun 21.

 

  • Schroecksnadel S, Maier E, Jenny M, Kurz K, Ueberall F, Fuchs F. Beeinflussung immunologischer Regelkreise durch Konservierungsmittel und Farbstoffe in vitro, Allergologie, 2011, 34 (4): 200-211.

 

  • Eder B, Überall F. Do chronic fatigue syndrome and atherosclerosis share common molecular risk factors. Schweiz Z Ganzheitsmed, 2011, 23: 109-120.

 

  • Wrulich OA, Überall F. DNS-Mikroarrays- Verbesserung der analytischen Plattformen zur Beschreibung molekularer Wirkmuster von Naturstoffpräparaten oder Science Fiction? Schweiz Z Ganzheitsmed, 2009, 21: 348-355.

 

  • Wrulich OA, Jenny M, Überall F. Molekulare Risiko- und Nutzenbewertung von Phytopharmaka. Neue Herausforderungen oder unerfüllbare Vorgaben?, J. Phytotherapie, 2009, 2: 7-13.

 

  • Ueberall F, Fuchs D, Vennos Cecile. Das anti-inflammatorische Potential von Padma 28, Übersicht experimenteller Daten zur antiatherogenen Wirkung und Diskussion des Vielstoffkonzeptes, Forsch Komplementärmed, 2006, 13: 7-14.

 

  • Jenny M, Wrulich OA, Schwaiger W, Überall F. Relevance of atypical protein kinase C isotypes in the drug discovery process. ChemBioChem, 2005, 6: 1-9.

 

  • Geiger M, Wrulich OA, Jenny M, Schwaiger W, Grunicke HH, Überall F. Defining the human targets of phorbol ester and diacylglycerol, Current Opinion in Molecular Therapeutics, 2003, 5: 631-641.

 

  • Hans H. Grunicke, Karl Maly, Inge Tinhofer, Sabine Giselbrecht, Sonja Kampfer, Gottfried Baier, and Florian Überall. Inhibition of phospholipase C and protein kinase C by alkyl-phosphocholines. Drugs of Today, 1998, 34: 100-113.

 

  • Hans H. Grunicke, Karl Maly, Inge Tinhofer, Sabine Giselbrecht, Sonja Kampfer, Gottfried Baier, and Florian Überall. Inhibition of phospholipase C and protein kinase C by alkyl-phosphocholines. Drugs of Today, 1998, 34: 100-113.

 

  • Geiger M, Wrulich OA, Jenny M, Schwaiger W, Grunicke HH, Überall F. Defining the human targets of phorbol ester and diacylglycerol, Current Opinion in Molecular Therapeutics, 2003, 5: 631-641.

 

  • Jenny M, Wrulich OA, Schwaiger W, Überall F. Relevance of atypical protein kinase C isotypes in the drug discovery process. ChemBioChem, 2005, 6: 1-9.

 

  • Ueberall F, Fuchs D, Vennos Cecile. Das anti-inflammatorische Potential von Padma 28, Übersicht experimenteller Daten zur antiatherogenen Wirkung und Diskussion des Vielstoffkonzeptes, Forsch Komplementärmed, 2006, 13: 7-14.

 

  • Wrulich OA, Jenny M, Überall F. Molekulare Risiko- und Nutzenbewertung von Phytopharmaka. Neue Herausforderungen oder unerfüllbare Vorgaben?, J. Phytotherapie, 2009, 2: 7-13.

 

  • Wrulich OA, Überall F. DNS-Mikroarrays- Verbesserung der analytischen Plattformen zur Beschreibung molekularer Wirkmuster von Naturstoffpräparaten oder Science Fiction? Schweiz Z Ganzheitsmed, 2009, 21: 348-355.

 

  • Eder B, Überall F. Do chronic fatigue syndrome and atherosclerosis share common molecular risk factors. Schweiz Z Ganzheitsmed, 2011, 23: 109-120.

 

  • Schroecksnadel S, Maier E, Jenny M, Kurz K, Ueberall F, Fuchs F. Beeinflussung immunologischer Regelkreise durch Konservierungsmittel und Farbstoffe in vitro, Allergologie, 2011, 34 (4): 200-211.